pd 98059 has been researched along with sermorelin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barabutis, N; Schally, AV; Siejka, A | 1 |
Badiavas, EV; Block, NL; Cai, R; Cui, T; Jimenez, JJ; Perez, R; Rodriguez-Menocal, L; Schally, AV; Sha, W; Vila Granda, A; Zarandi, M | 1 |
2 other study(ies) available for pd 98059 and sermorelin
Article | Year |
---|---|
Growth hormone releasing hormone induces the expression of nitric oxide synthase.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cyclooxygenase 2; Flavonoids; Growth Hormone-Releasing Hormone; Humans; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Reactive Oxygen Species; Sermorelin | 2011 |
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways.
Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Dermis; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Growth Hormone-Releasing Hormone; Humans; Male; Mice, Inbred C57BL; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Sermorelin; Signal Transduction; Wound Healing | 2016 |